Dopavision is a therapeutic company developing a digital therapeutic for myopia.
Dopavision has raised $14.2M in total funding. The most recent round was Series A. The last funding was announced in July 2021.
Dopavision's investors include Seventure Partners, Boehringer Ingelheim Venture Fund, dRx Capital, Novartis Pharma, Flyinghealth.
Dopavision is headquartered in Berlin, Germany.
Dopavision is a therapeutic company developing a digital therapeutic for myopia.
Dopavision is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dopavision — Funding & Investors." VCBacked, July 14, 2021, https://www.vcbacked.co/company/dopavision. Accessed August 14, 2026.
VCBacked. (2021). Dopavision — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/dopavision
{{cite web |title=Dopavision — Funding & Investors |url=https://www.vcbacked.co/company/dopavision |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated